Holen Sie sich die Stockscreener-App
91.74
0.30%
0.27
Handel nachbörslich:
91.74
Schlusskurs vom Vortag:
$91.47
Offen:
$91.92
24-Stunden-Volumen:
102.17K
Relative Volume:
0.71
Marktkapitalisierung:
$2.06B
Einnahmen:
$213.03M
Nettoeinkommen (Verlust:
$41.32M
KGV:
50.13
EPS:
1.83
Netto-Cashflow:
$33.49M
1W Leistung:
-1.18%
1M Leistung:
-12.65%
6M Leistung:
+12.84%
1J Leistung:
+69.79%
1-Tages-Spanne:
$91.05
$92.96
1-Wochen-Bereich:
$90.45
$94.20
52-Wochen-Spanne:
$52.88
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Vergleichen Sie LMAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
91.74 | 2.06B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
535.29 | 190.66B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
228.46 | 66.26B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.06 | 41.58B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.67 | 34.01B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
335.56 | 24.30B | 2.88B | 499.60M | 321.60M | 6.74 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
Sanctuary Advisors LLC Makes New $181,000 Investment in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stake Increased by Franklin Resources Inc. - Defense World
Jane Street Group LLC Reduces Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Jane Street Group LLC - MarketBeat
(LMAT) Pivots Trading Plans and Risk Controls - Stock Traders Daily
4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow - Yahoo Finance
Barclays PLC Boosts Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by Barclays PLC - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Geode Capital Management LLC Acquires 23,443 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives $94.57 Average PT from Brokerages - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Has More To Do To Multiply In Value Going Forward - Simply Wall St
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by HighTower Advisors LLC - Defense World
LeMaitre Vascular prices $150M convertible senior notes - MSN
LeMaitre Vascular Prices $150 Million Convertible Senior Notes - Defense World
LeMaitre Vascular's SWOT analysis: niche market leader faces valuation scrutiny - Investing.com
December 2025 Options Now Available For LeMaitre Vascular (LMAT) - Nasdaq
State Street Corp Buys 28,525 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular Announces $150 Million Convertible Senior Notes OfferingUnited States-based medical device company LeMaitre Vascular, Inc. (NASDAQ: LMAT) revealed its plans for a substantial financial move on December 16, 2024. The company disc - Defense World
LeMaitre Vascular (NASDAQ:LMAT) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Fmr LLC Buys 8,114 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular Prices $150M Convertible Notes Offering - TipRanks
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Holdings Boosted by Fmr LLC - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Shares Gap DownShould You Sell? - MarketBeat
LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering - The Manila Times
LeMaitre Vascular to Offer $150M in Convertible Notes - TipRanks
M&T Bank Corp Buys New Shares in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Crude Oil Brent (SCK24) Quote - The Globe and Mail
Ultra Bloomberg Natural Gas 2X ETF (BOIL-A) QuotePress Release - The Globe and Mail
Stifel Financial Corp Has $6.71 Million Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock Position Decreased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
LeMaitre Vascular's SWOT analysis: niche market leader's stock faces valuation scrutiny - Investing.com India
StockNews.com Downgrades LeMaitre Vascular (NASDAQ:LMAT) to Hold - MarketBeat
Janus Henderson Group PLC Reduces Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
United Rentals (URI-N) QuotePress Release - The Globe and Mail
TSX Composite High Beta Index (TXHB) QuotePress Release - The Globe and Mail
Transdigm Group Inc (TDG-N) QuotePress Release - The Globe and Mail
Cardiac Valvulotome Market Top Companies StudyLeMaitre, - openPR
LeMaitre Vascular (NASDAQ:LMAT) sheds 5.5% this week, as yearly returns fall more in line with earnings growth - Simply Wall St
Charles Schwab Investment Management Inc. Has $17.79 Million Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Charles Schwab Investment Management Inc. Has $17.79 Million Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
BNP Paribas Financial Markets Purchases 12,432 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Stock Rating Upgraded by StockNews.com - Defense World
(LMAT) Trading Advice - Stock Traders Daily
Bridgewater Associates LP Sells 15,389 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Brokerages Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) Target Price at $94.57 - Defense World
Townsquare Capital LLC Acquires 13,210 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Strategic Sale: James John OConnor Decides To Exercise Options Worth $527K At LeMaitre Vascular - Benzinga
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Brokerages Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) Price Target at $94.57 - MarketBeat
Witnessing An Insider Decision, George LeMaitre Exercises Options Valued At $187K At LeMaitre Vascular - Benzinga
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lemaitre Vascular Inc-Aktie (LMAT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Roberts David B | President and Director |
Dec 20 '24 |
Option Exercise |
0.00 |
17 |
0 |
14,657 |
| Pellegrino Joseph P JR | Chief Financial Officer |
Dec 20 '24 |
Option Exercise |
0.00 |
17 |
0 |
9,248 |
| Kamke Trent G | Senior V. P., Operations |
Dec 20 '24 |
Option Exercise |
0.00 |
9 |
0 |
5,129 |
| Jasinski Lawrence J | Director |
Dec 12 '24 |
Option Exercise |
0.00 |
6 |
0 |
5,544 |
| Jasinski Lawrence J | Director |
Dec 11 '24 |
Option Exercise |
0.00 |
6 |
0 |
5,538 |
| Roberts David B | President and Director |
Dec 12 '24 |
Option Exercise |
0.00 |
22 |
0 |
15,034 |
| Roberts David B | President and Director |
Dec 11 '24 |
Option Exercise |
0.00 |
18 |
0 |
15,208 |
| Pellegrino Joseph P JR | Chief Financial Officer |
Dec 12 '24 |
Option Exercise |
0.00 |
22 |
0 |
9,827 |
| Pellegrino Joseph P JR | Chief Financial Officer |
Dec 11 '24 |
Option Exercise |
0.00 |
18 |
0 |
10,099 |
| O'Connor John James | Director |
Dec 12 '24 |
Option Exercise |
0.00 |
6 |
0 |
57,096 |
2.64%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):